Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence
Authors:
- 9 March 2023
- journal article
- research article
- Published by Springer Nature in Brain Tumor Pathology
- Vol. 40 (2) , 109-123
Abstract
Pilocytic astrocytomas (PAs) are benign tumors. However, clinically aggressive PAs despite benign histology have been reported, and histological and molecular risk factors for prognosis have not been elucidated. 38 PAs were studied for clinical, histological, and molecular factors, including tumor location, extent of resection, post-operative treatment, glioma-associated molecules (IDH1/2, ATRX, BRAF, FGFR1, PIK3CA, H3F3A, p53, VEGF, Nestin, PD-1/PD-L1), CDKN2A/B deletion, and chromosomal number aberrations, to see if there is any correlation with patient’s progression-free survival (PFS). Brainstem/spinal location, extent of resection and post-operative treatment, and VEGF-A, Nestin and PD-L1 expression, copy number gain of chromosome 7q or 19, TP53 mutation were significantly associated with shorter PFS. None of the histological parameters was associated with PFS. Multivariate analyses demonstrated that high Nestin expression, gain of 7q or 19, and extent of removal were independently predictive for early tumor recurrence. The brainstem/spinal PAs appeared distinct from those in the other sites in terms of molecular characteristics. Clinically aggressive PAs despite benign histology exhibited high Nestin expression. Brainstem/spinal location, extent of resection and some molecular factors including Nestin expression and gains of 7q and 19, rather than histological parameters, may be associated with early tumor recurrence in PAs.Keywords
Funding Information
- Japan Society for the Promotion of Science (18J21382, 24791563)
This publication has 73 references indexed in Scilit:
- Treatment, prognostic factors, and outcomes in spinal cord astrocytomasNeuro-Oncology, 2013
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomasBrain Tumor Pathology, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Clinical review of pediatric pilocytic astrocytomas treated at a tertiary care hospital in PakistanSurgical Neurology International, 2012
- BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade AstrocytomaClinical Cancer Research, 2011
- Primary Cerebellar Pilocytic Astrocytoma With Anaplastic Features in a Patient With Neurofibromatosis Type 1 -Case Report-Neurologia medico-chirurgica, 2011
- PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytomaActa Neuropathologica, 2010
- Nestin expression in astrocytic tumors delineates tumor infiltrationBrain Tumor Pathology, 2010
- 19q13 amplification is associated with high grade and stage in pancreatic cancerGenes, Chromosomes and Cancer, 2010
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009